1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Lung Inflammation: new trials by email Literature Review of Lung Inflammation trials Research Report on Lung Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease | Phase 1 | Terminated | Synspira, Inc. | 32 | 2017-09-28 | 2018-05-25 |
Burkholderia Infections (1) · Cystic Fibrosis (1) · Infections (1) · Lung Diseases (1) · Mycobacterium Infections, Nontuberculous (1) · Pneumonia (1) · Respiratory Tract Diseases (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Gram-Negative Bacterial Infections (1) · Gram-Positive Bacterial Infections (1) · Infant, Newborn, Diseases (1) · Mycobacterium Infections (1) · Pancreatic Diseases (1) · Respiratory Tract Infections (1)
Synspira, Inc. (1)
United Kingdom (1)